Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients

BACKGROUND: Anti-Androgen Receptor (AR) therapy holds promise for a subset of AR expressing triple-negative breast cancer (TNBC) patients. However, current AR assays are suboptimal in detecting the dynamic range of AR expression, contributing to its controversial role in TNBC disease prognosis. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Govindan, Sindhu, Siraganahalli Eswaraiah, Mallikarjuna, Basavaraj, Chetana, Adinarayan, Manjula, Sankaran, Satish, Bakre, Manjiri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419184/
https://www.ncbi.nlm.nih.gov/pubmed/32778063
http://dx.doi.org/10.1186/s12885-020-07218-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419184/
https://www.ncbi.nlm.nih.gov/pubmed/32778063
http://dx.doi.org/10.1186/s12885-020-07218-0

Ejemplares similares